Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

The role of γδT-cells in causing alopecia areata remains unclear.

MPA increases cancer spread by boosting Eph A2 activity.

TPA is about 50 times more effective at promoting tumors than MZ.

Hair matrix cysts are rare skin nodules with unique features, often needing surgical removal.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

A woman's hair turned white after taking a cancer drug called dasatinib.

The study identified key immune cell differences between mild and severe alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

EGFR helps hair follicles transition properly by controlling Stathmin levels.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

CTIP2 may help in skin development and maintenance.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

AP-1 controls tumor cell type by affecting key signaling pathways.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Laser-pretreated blood for hair loss treatment was more effective and increased stem cells.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.